Received Aug 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | — |
Shingrix Potential 3rd dose; Shingrix Potential 3rd dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on an unknown date) and Shingrix (2nd dose received on an unknown date). On an unknown date, the patient did not receive the 3rd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: Shingrix Potential 3rd dose) and circumstance or information capable of leading to medication error (Verbatim: Shingrix Potential 3rd dose). The outcome of the extra dose administered and circumstance or information capable of leading to medication error were not applicable. Additional Information: GSK receipt date: 01-AUG-2025 It was reported that a patient who went to pharmacy for her first Shingrix shot. Upon returning for her second shot, the pharmacy told her they gave her the Covid shot the first time and not Shingrix. The patient thought the pharmacy messed up the records and that she distinctly remembers getting Shingrix. The pharmacy gave her the subsequent Shingrix vaccine and set her up again to complete the series which led to extra dose administered and circumstance or information capable of leading to medication error. The patient would like to know the safety of getting 3 Shingrix vaccines in case the pharmacy did make a clerical error.